2024-04-01 2025-03-31 false Capium Accounts Production 1.1 10709665 2024-04-01 2025-03-31 10709665 bus:AbridgedAccounts 2024-04-01 2025-03-31 10709665 bus:FRS102 2024-04-01 2025-03-31 10709665 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 10709665 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 10709665 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10709665 2024-04-01 2025-03-31 10709665 2025-03-31 10709665 bus:RegisteredOffice 2024-04-01 2025-03-31 10709665 core:WithinOneYear 2025-03-31 10709665 core:AfterOneYear 2025-03-31 10709665 1 2024-04-01 2025-03-31 10709665 bus:Director1 2024-04-01 2025-03-31 10709665 bus:Director1 2025-03-31 10709665 bus:Director1 2023-04-01 2024-03-31 10709665 2023-04-01 10709665 bus:LeadAgentIfApplicable 2024-04-01 2025-03-31 10709665 2023-04-01 2024-03-31 10709665 2024-03-31 10709665 core:WithinOneYear 2024-03-31 10709665 core:AfterOneYear 2024-03-31 10709665 bus:EntityAccountantsOrAuditors 2023-04-01 2024-03-31 10709665 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 10709665 bus:OrdinaryShareClass1 2025-03-31 10709665 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 10709665 bus:OrdinaryShareClass1 2024-03-31 10709665 core:ComputerEquipment 2024-04-01 2025-03-31 10709665 core:ComputerEquipment 2025-03-31 10709665 core:ComputerEquipment 2024-03-31 10709665 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-03-31 10709665 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-03-31 10709665 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 10709665 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 10709665 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 10709665 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 10709665 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 10709665 core:Non-currentFinancialInstruments 2025-03-31 10709665 core:Non-currentFinancialInstruments 2024-03-31 10709665 core:ShareCapital 2025-03-31 10709665 core:ShareCapital 2024-03-31 10709665 core:RetainedEarningsAccumulatedLosses 2025-03-31 10709665 core:RetainedEarningsAccumulatedLosses 2024-03-31 10709665 dpl:Item1 2024-04-01 10709665 dpl:Item1 2025-03-31 10709665 dpl:Item1 2023-04-01 10709665 dpl:Item1 2024-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 10709665
England and Wales

 

 

 


Abridged Accounts


for the year ended 31 March 2025

for

WARWICK HIP AND KNEE SURGERY LTD

 
 
Notes
 
2025
£
  2024
£
Fixed assets      
Tangible fixed assets 3 1,353    1,083 
1,353    1,083 
Current assets      
Debtors 53,049    69,296 
Cash at bank and in hand 59,956    80,547 
113,005    149,843 
Creditors: amount falling due within one year (48,666)   (54,562)
Net current assets 64,339    95,281 
 
Total assets less current liabilities 65,692    96,364 
Net assets 65,692    96,364 
 

Capital and reserves
     
Called up share capital 4 100    100 
Profit and loss account 65,592    96,264 
Shareholders' funds 65,692    96,364 
 


For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The director of the company has elected not to include the Income Statement within the financial statements. 
The financial statements were approved by the director on 24 December 2025 and were signed by:


-------------------------------
Dr M Faisal
Director
1
General Information
Warwick Hip and Knee Surgery Ltd is a company limited by shares and is incorporated in England and Wales. The address of the registered office is C/O Bluewater, Quadrant Court, 49 Calthorpe Road, Birmingham, B15 1TH. The nature of the company's operations and its principal activity was the provision of medical services.
1.

Accounting policies

Significant accounting policies
The company's financial statements have been prepared in compliance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the United Kingdom and the Republic of Ireland' and the Companies Act 2006.

The financial statements have been prepared under the historical cost convention and on a going concern basis. The financial statements comprise the unaudited financial statements of the company up to 31 March each year, and are stated in pound sterling, the company's functional and presentational currency.

The principal accounting policies applied in the preparation of these financial statements are set out below, these policies have been applied consistently to all the years presented, unless otherwise stated.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company.
Operating lease rentals
Rentals payable under operating leases are charged against income on a straight line basis over the lease term.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis: 
Computer Equipment 33% Straight Line
2.

Employees and Directors


Average number of employees during the year was 1 (2024 : 1).
3.

Tangible fixed assets

Cost or valuation Computer Equipment   Total
  £   £
At 01 April 2024 1,617    1,617 
Additions 1,199    1,199 
Disposals  
At 31 March 2025 2,816    2,816 
Depreciation
At 01 April 2024 534    534 
Charge for year 929    929 
On disposals  
At 31 March 2025 1,463    1,463 
Net book values
Closing balance as at 31 March 2025 1,353    1,353 
Opening balance as at 01 April 2024 1,083    1,083 


4.

Share Capital

Allotted, called up and fully paid
2025
£
  2024
£
100 Ordinary shares of £1.00 each 100    100 
100    100 

2